Cysteine proteases as disease markers
I Berdowska - Clinica chimica acta, 2004 - Elsevier
This review comprises issues concerning cysteine cathepsins (CCs): human peptidases
belonging to papain family (C1) of clan CA of cysteine proteases: cathepsins B, L, H, S, K, F …
belonging to papain family (C1) of clan CA of cysteine proteases: cathepsins B, L, H, S, K, F …
[HTML][HTML] Proteolytic-antiproteolytic balance and its regulation in carcinogenesis
E Skrzydlewska, M Sulkowska, M Koda… - World journal of …, 2005 - ncbi.nlm.nih.gov
Cancer development is essentially a tissue remodeling process in which normal tissue is
substituted with cancer tissue. A crucial role in this process is attributed to proteolytic …
substituted with cancer tissue. A crucial role in this process is attributed to proteolytic …
Prognostic impact of proteolytic factors (urokinase-type plasminogen activator, plasminogen activator inhibitor 1, and cathepsins B, D, and L) in primary breast cancer …
N Harbeck, U Alt, U Berger, A Krüger… - Clinical Cancer …, 2001 - AACR
Purpose: Prognostic and predictive impact of five proteolytic factors associated with tumor
invasion and metastasis in primary breast cancer were evaluated after long-term follow-up …
invasion and metastasis in primary breast cancer were evaluated after long-term follow-up …
[HTML][HTML] The urokinase plasminogen activation system in gastroesophageal cancer: A systematic review and meta-analysis
Background The urokinase plasminogen activation (uPA) system is a crucial pathway for
tumour invasion and establishment of metastasis. Although there is good evidence that uPA …
tumour invasion and establishment of metastasis. Although there is good evidence that uPA …
[HTML][HTML] Cathepsin D expression levels in nongynecological solid tumors: clinical and therapeutic implications
G Leto, FM Tumminello, M Crescimanno… - Clinical & experimental …, 2004 - Springer
Cathepsin D is a lysosomal acid proteinase which is involved in the malignant progression
of breast cancer and other gynecological tumors. Clinical investigations have shown that in …
of breast cancer and other gynecological tumors. Clinical investigations have shown that in …
COX-2 is associated with proliferation and apoptosis markers and serves as an independent prognostic factor in gastric cancer
J Mrena, JP Wiksten, A Kokkola, S Nordling… - Tumor Biology, 2010 - Springer
Abstract Cyclooxygenase-2 (COX-2) is an important factor in gastric carcinogenesis, and
COX-2 expression in gastric cancer patients correlates with prognosis. We have now studied …
COX-2 expression in gastric cancer patients correlates with prognosis. We have now studied …
Comparative expression patterns and diagnostic efficacies of SR splicing factors and HNRNPA1 in gastric and colorectal cancer
WC Park, HR Kim, DB Kang, JS Ryu, KH Choi, GO Lee… - BMC cancer, 2016 - Springer
Background Serine/arginine-rich splicing factors (SRSFs) and HNRNPA1 have oncogenic
properties. However, their proteomic expressions and practical priority in gastric cancer (GC) …
properties. However, their proteomic expressions and practical priority in gastric cancer (GC) …
Cathepsin D as a promising target for the discovery of novel anticancer agents
V Dubey, S Luqman - Current cancer drug targets, 2017 - ingentaconnect.com
Background: Cathepsin D (CATD), one of the aspartyl endoproteinase involved in different
physiological processes and signaling pathways, is accountable for metabolic breakdown of …
physiological processes and signaling pathways, is accountable for metabolic breakdown of …
Is phage display technology on target for developing peptide-based cancer drugs?
LA Landon, J Zou, SL Deutscher - Current drug discovery …, 2004 - ingentaconnect.com
New tumor targeting agents are required to advance cancer diagnosis and treatment.
Bacteriophage (phage) display technology, a molecular genetic means of combinatorial …
Bacteriophage (phage) display technology, a molecular genetic means of combinatorial …
Cathepsin B, plasminogenactivator-inhibitor (PAI-1) and plasminogenactivator-receptor (uPAR) are prognostic factors for patients with non-small cell lung cancer
B Werle, M Kotzsch, TT Lah, J Kos… - Anticancer …, 2004 - ar.iiarjournals.org
To evaluate the possible role of cysteine proteases and serine proteases, as well as their
respective inhibitors and receptors, as new prognostic factors in NSCLC, we examined, for …
respective inhibitors and receptors, as new prognostic factors in NSCLC, we examined, for …